Deal Announcements

AdvanDx Adds Venture Capital Equity Funding

Tuesday, October 30, 2012 5:33:00 AM PDT | VentureDeal

Woburn, Massachusetts  --  Biotechnology company AdvanDx has received $2.16 million in new venture capital financing, according to an SEC regulatory filing.

AdvanDx sells molecular-based, in vitro diagnostic tests focused on infectious disease diagnosis.

Investors in the round were not disclosed, nor was how the company intends to use the proceeds.

AdvanDx is still seeking $3.9 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1